Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ric N Price

Showing results (291-300 of 318) with videos related to

Pageof 32
Sort By:
Science Translational Medicine|March 22, 2013
Quinolone-3-diarylethers: a new class of antimalarial drugAaron Nilsen, Alexis N LaCrue, Karen L White, et al.
Malaria Journal|January 4, 2026
Moving towards high-dose primaquine or single-dose tafenoquine for Plasmodium vivax treatment in Cambodia: a meeting report from dissemination of results of the EFFORT trial to stakeholdersLek Dysoley, Sarah Cassidy-Seyoum, Bipin Adhikari, et al.
Lancet (London, England)|June 24, 2019
Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000-17: a spatial and temporal modelling studyKatherine E Battle, Tim C D Lucas, Michele Nguyen, et al.
Malaria Journal|October 11, 2023
Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysisParinaz Mehdipour, Megha Rajasekhar, Saber Dini, et al.
Lancet (London, England)|July 23, 2019
Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trialWalter R J Taylor, Kamala Thriemer, Lorenz von Seidlein, et al.
The Lancet. Child & Adolescent Health|September 27, 2024
Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysisRobert J Commons, Megha Rajasekhar, Elizabeth N Allen, et al.
BMC Medicine|September 15, 2022
Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient dataKasia Stepniewska, Elizabeth N Allen, Georgina S Humphreys, et al.
Plos Medicine|July 25, 2020
Correction: Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysisDaniel A Pfeffer, Benedikt Ley, Rosalind E Howes, et al.
Plos Medicine|May 15, 2020
Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysisDaniel A Pfeffer, Benedikt Ley, Rosalind E Howes, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2018
UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of MalariaChristel Brunschwig, Nina Lawrence, Dale Taylor, et al.
Pageof 32

Showing results (291-300 of 318) with videos related to

Sort By:
Pageof 32
Science Translational Medicine|March 22, 2013
Quinolone-3-diarylethers: a new class of antimalarial drugAaron Nilsen, Alexis N LaCrue, Karen L White, et al.
Malaria Journal|January 4, 2026
Moving towards high-dose primaquine or single-dose tafenoquine for Plasmodium vivax treatment in Cambodia: a meeting report from dissemination of results of the EFFORT trial to stakeholdersLek Dysoley, Sarah Cassidy-Seyoum, Bipin Adhikari, et al.
Lancet (London, England)|June 24, 2019
Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000-17: a spatial and temporal modelling studyKatherine E Battle, Tim C D Lucas, Michele Nguyen, et al.
Malaria Journal|October 11, 2023
Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysisParinaz Mehdipour, Megha Rajasekhar, Saber Dini, et al.
Lancet (London, England)|July 23, 2019
Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trialWalter R J Taylor, Kamala Thriemer, Lorenz von Seidlein, et al.
The Lancet. Child & Adolescent Health|September 27, 2024
Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysisRobert J Commons, Megha Rajasekhar, Elizabeth N Allen, et al.
BMC Medicine|September 15, 2022
Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient dataKasia Stepniewska, Elizabeth N Allen, Georgina S Humphreys, et al.
Plos Medicine|July 25, 2020
Correction: Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysisDaniel A Pfeffer, Benedikt Ley, Rosalind E Howes, et al.
Plos Medicine|May 15, 2020
Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysisDaniel A Pfeffer, Benedikt Ley, Rosalind E Howes, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2018
UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of MalariaChristel Brunschwig, Nina Lawrence, Dale Taylor, et al.
Pageof 32